Department of Urology Grand Rounds: Jonathan Pavlinec, MD

The University of Florida Department of Urology invites you to attend
Grand Rounds

 Jonathan Pavlinec_MCM_8786

Testosterone and Prostate Cancer: Past, Present, and Future

Jonathan Pavlinec, MD
Department of Urology
University of Florida

Wednesday, April 20, 2016
7:00 am
Department of Urology Conference Room

 Learning Objectives:

Evaluate historical context of testosterone and hormonal nature of prostate cancer (PCa)
Review the “Androgen Hypothesis,” and flaws exposed by the literature
Understand implications of the “Saturation Model”
Discuss benefits of testosterone therapy (TTh) in hypogonadal men
Review available data evaluating TTh and risk of Pca
Discuss recent data on TTh in men with history of PCa
Appreciate current studies of TTh with PCa on Active Surveillance
Introduce concept of Bipolar Androgen Therapy
Review FDA warning on TTh and barriers to paradigm shift from historical views
Present current guidelines on TTh as related to surveillance and risk of PCa

   Target Audience:

Urologists, Residents, Nurses, Physician Assistants, and Staff

Accreditation:

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.

Credit:

The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Support:

The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.

Contact Information:

If you have any questions please feel free to contact Chris Emery at christine.emery@urology.ufl.edu.

Disclosure:

Dr. Pavlinec has disclosed that he has no relevant financial relationships. No one else in a position to control content has any financial relationship to disclose.

 

Section Number: 6124

US NEWS AND WORLD REPORT BADGES

Florida’s Leading Academic Urology Program

Rated as High Performing Urology Program

Rated as High Performing in Prostate Cancer Surgery